Patents by Inventor Andrew Leitner
Andrew Leitner has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 12702642Abstract: A method and kit for the sequential early introduction to an infant of at least nine allergens to decrease the infant's risk for developing allergies. The method and kit includes an initial lower exposure dose of a first allergen to be taken for a day or two, followed by a higher maintenance dose of the first allergen to be taken for a day or more. Additional allergens are added, each first at an initial lower dose for a day or more followed by a higher maintenance dose for a day or more. This patent continues until all nine allergens are being given to an infant at their maintenance doses. The allergens can be provided in powdered protein form in premeasured pouches for addition to baby formula/mother's milk. Alternatively, the allergens can be included in baby formula, or in other foods such as snack bars, cookies, or gels.Type: GrantFiled: February 16, 2023Date of Patent: August 11, 2026Assignee: ATG ACQUISITION LLCInventors: Andrew Leitner, Katie Marks, Aaron Rowe, Daniel Zakowski, Erika Nolte
-
Patent number: 11878916Abstract: The present invention relates to a new synthetic manganese oxide material, a method of synthesis of the new manganese oxide material, and use of the new synthetic manganese oxide as a secondary battery active cathode material in an electrochemical application.Type: GrantFiled: June 20, 2019Date of Patent: January 23, 2024Assignee: IONIC MATERIALS, INC.Inventors: Alexei B. Gavrilov, Andrew Leitner
-
Publication number: 20230414497Abstract: A method for the early introduction to an infant between the ages of two to four months of at least three allergens to decrease the infant's risk for developing allergies. The method includes the steps of administering to the infant a first allergen selected from the group consisting of cow's milk, hen's egg, peanut, cashew, pistachio, almond, walnuts, pecans, hazelnut, wheat, soy, sesame for multiple days. Next the infant in administered, in addition to the first allergen, a second allergen different from the first allergen selected from the same group of allergens, and third, subsequently administering to the infant, in addition to the first allergen and the second allergen, a third allergen different from the first allergen and the second allergen, a third allergen being selected from the same group of allergens for multiple days.Type: ApplicationFiled: September 8, 2023Publication date: December 28, 2023Inventors: Andrew Leitner, Katie Marks, Aaron Rowe, Daniel Zakowski
-
Publication number: 20230395874Abstract: Electrospun polymers are disclosed for use in lithium-ion electrochemical cells. The disclosed electrospun polymers may be positioned between the cathode and a solid-state electrolyte to enhance the Li-ion cell's performance, safety, and resiliency to mechanical failure.Type: ApplicationFiled: June 1, 2023Publication date: December 7, 2023Inventors: Ariel Jackson, Mohamed Taggougui, Ahmed Al-Obeidi, Andrew Leitner, Zhiyong Meng, Joseph X. Adiletta, Vikram Sharma
-
Patent number: 11786459Abstract: A kit for the sequential early introduction to an infant of at least two allergens to decrease the infant's risk for developing allergies, the kit including an initial lower, exposure dose of a first allergen to be taken for a day or two, a higher maintenance dose of the first allergen to be taken for several days, a maintenance dose of the first allergen and an initial lower, exposure dose of a second allergen to be taken for a day or two, and the higher maintenance dose of the first allergen and a higher maintenance does of the second allergen to be taken for several days. The allergens can be provided in powdered protein form in premeasured pouches for addition to baby formula or to mother's milk. Alternatively, the allergens can already be provided in baby formula, or in other foods such as snack bars, cookies, or gels.Type: GrantFiled: November 25, 2020Date of Patent: October 17, 2023Assignee: PROLLERGY CORPORATIONInventors: Andrew Leitner, Katie Marks, Aaron Rowe, Daniel Zakowski
-
Publication number: 20230190645Abstract: A method and kit for the sequential early introduction to an infant of at least nine allergens to decrease the infant's risk for developing allergies. The method and kit includes an initial lower exposure dose of a first allergen to be taken for a day or two, followed by a higher maintenance dose of the first allergen to be taken for a day or more. Additional allergens are added, each first at an initial lower dose for a day or more followed by a higher maintenance dose for a day or more. This patent continues until all nine allergens are being given to an infant at their maintenance doses. The allergens can be provided in powdered protein form in premeasured pouches for addition to baby formula/mother's milk. Alternatively, the allergens can be included in baby formula, or in other foods such as snack bars, cookies, or gels.Type: ApplicationFiled: February 16, 2023Publication date: June 22, 2023Inventors: Andrew Leitner, Katie Marks, Aaron Rowe, Daniel Zakowski, Erika Nolte
-
Patent number: 11173113Abstract: A method and kit for the sequential early introduction to an infant of at least two allergens to decrease the infant's risk for developing allergies, the method involving administering an initial lower, exposure dose of a first allergen for a day or two, followed by administering a higher maintenance dose of the first allergen for several days, followed by administering the maintenance dose of the first allergen and an initial lower, exposure dose of a second allergen for a day or two, followed by administering the higher maintenance dose of the first allergen and a higher maintenance does of the second allergen for several days. The allergens can be provided in powdered protein form in premeasured pouches for addition to baby formula or to mother's milk. Alternatively, the allergens can already be provided in baby formula, or in other foods such as snack bars, cookies, or gels.Type: GrantFiled: November 21, 2018Date of Patent: November 16, 2021Assignee: PROLLERGY CORPORATIONInventors: Andrew Leitner, Katie Marks, Aaron Rowe, Daniel Zakowski
-
Publication number: 20210253443Abstract: The present invention relates to a new synthetic manganese oxide material, a method of synthesis of the new manganese oxide material, and use of the new synthetic manganese oxide as a secondary battery active cathode material in an electrochemical application.Type: ApplicationFiled: June 20, 2019Publication date: August 19, 2021Inventors: Alexei B. Gavrilov, Andrew Leitner
-
Publication number: 20210077387Abstract: A kit for the sequential early introduction to an infant of at least two allergens to decrease the infant's risk for developing allergies, the kit including an initial lower, exposure dose of a first allergen to be taken for a day or two, a higher maintenance dose of the first allergen to be taken for several days, a maintenance dose of the first allergen and an initial lower, exposure dose of a second allergen to be taken for a day or two, and the higher maintenance dose of the first allergen and a higher maintenance does of the second allergen to be taken for several days. The allergens can be provided in powdered protein form in premeasured pouches for addition to baby formula or to mother's milk. Alternatively, the allergens can already be provided in baby formula, or in other foods such as snack bars, cookies, or gels.Type: ApplicationFiled: November 25, 2020Publication date: March 18, 2021Inventors: Andrew Leitner, Katie Marks, Aaron Rowe, Daniel Zakowski
-
Patent number: 10894013Abstract: A method and kit for the sequential early introduction to an infant of at least two allergens to decrease the infant's risk for developing allergies, the method involving administering an initial lower, exposure dose of a first allergen for a day or two, followed by administering a higher maintenance dose of the first allergen for several days, followed by administering the maintenance dose of the first allergen and an initial lower, exposure dose of a second allergen for a day or two, followed by administering the higher maintenance dose of the first allergen and a higher maintenance does of the second allergen for several days. The allergens can be provided in powdered protein form in premeasured pouches for addition to baby formula or to mother's milk. Alternatively, the allergens can already be provided in baby formula, or in other foods such as snack bars, cookies, or gels.Type: GrantFiled: December 10, 2019Date of Patent: January 19, 2021Assignee: PROLLERGY CORPORATIONInventors: Andrew Leitner, Katie Marks, Aaron Rowe, Daniel Zakowski
-
Publication number: 20200113822Abstract: A method and kit for the sequential early introduction to an infant of at least two allergens to decrease the infant's risk for developing allergies, the method involving administering an initial lower, exposure dose of a first allergen for a day or two, followed by administering a higher maintenance dose of the first allergen for several days, followed by administering the maintenance dose of the first allergen and an initial lower, exposure dose of a second allergen for a day or two, followed by administering the higher maintenance dose of the first allergen and a higher maintenance does of the second allergen for several days. The allergens can be provided in powdered protein form in premeasured pouches for addition to baby formula or to mother's milk. Alternatively, the allergens can already be provided in baby formula, or in other foods such as snack bars, cookies, or gels.Type: ApplicationFiled: December 10, 2019Publication date: April 16, 2020Inventors: Andrew Leitner, Katie Marks, Aaron Rowe, Daniel Zakowski
-
Publication number: 20190167577Abstract: A method and kit for the sequential early introduction to an infant of at least two allergens to decrease the infant's risk for developing allergies, the method involving administering an initial lower, exposure dose of a first allergen for a day or two, followed by administering a higher maintenance dose of the first allergen for several days, followed by administering the maintenance dose of the first allergen and an initial lower, exposure dose of a second allergen for a day or two, followed by administering the higher maintenance dose of the first allergen and a higher maintenance does of the second allergen for several days. The allergens can be provided in powdered protein form in premeasured pouches for addition to baby formula or to mother's milk. Alternatively, the allergens can already be provided in baby formula, or in other foods such as snack bars, cookies, or gels.Type: ApplicationFiled: November 21, 2018Publication date: June 6, 2019Inventors: Andrew Leitner, Katie Marks, Aaron Rowe, Daniel Zakowski